切换至 "中华医学电子期刊资源库"

中华诊断学电子杂志 ›› 2017, Vol. 05 ›› Issue (01) : 67 -70. doi: 10.3877/cma.j.issn.2095-655X.2017.01.018

所属专题: 文献

综述

肝纤维化无创性诊断方法的研究进展
左赛1, 孔令斌2,()   
  1. 1. 272069 济宁医学院附属医院消化内科
    2. 272016 济宁医学院临床学院
  • 收稿日期:2016-11-06 出版日期:2017-02-26
  • 通信作者: 孔令斌

Research advances of non-invasive diagnosis of liver fibrosis

Sai Zuo1, Lingbin Kong2,()   

  1. 1. Department of Gastroenterology, The Affiliatad Hospital of Jining Medical University, Jining 272069, China
    2. Clinical College of Jining Medical University, Jining 272016, China
  • Received:2016-11-06 Published:2017-02-26
  • Corresponding author: Lingbin Kong
  • About author:
    Corresponding author: Kong Lingbin, Email:
引用本文:

左赛, 孔令斌. 肝纤维化无创性诊断方法的研究进展[J]. 中华诊断学电子杂志, 2017, 05(01): 67-70.

Sai Zuo, Lingbin Kong. Research advances of non-invasive diagnosis of liver fibrosis[J]. Chinese Journal of Diagnostics(Electronic Edition), 2017, 05(01): 67-70.

肝纤维化是慢性肝病向终末期肝病进展的必经阶段,早期诊断并及时干预可以逆转,因此,肝纤维化的早期诊断备受关注。尽管目前肝纤维化诊断的金标准仍然为病理学诊断,但无创检查已逐渐成为临床发展的方向,主要包括血清肝纤维化标志物、影像学及其最新的分子生物学基因检测技术等无创诊断方法。为了临床合理选择肝纤维化诊断的方法,现将各种无创诊断方法的现状综述如下。

Liver fibrosis is an inevitable process of chronic liver diseases with different causes which may lead to end-stage liver diseases.If liver fibrosis patients are diagnosed and intervented timely, then the liver fibrosis can be reversed.In recent years, the non-invasive diagnosis of liver fibrosis gets widely attention, mainly including serologic markers, imaging diagnosis, genetics and so on.In order to select the appropriate live fibrosis diagnostic methods, the various non-invasive diagnostic methods of live fibrosis are summarized as follows.

[1]
崔东来,姚希贤. 肝纤维化的血清学检测[J]. 世界华人消化杂志, 2000, 8(4): 683-684.
[2]
刘婷,徐铭益. 肝纤维化的血清学诊断研究进展[J]. 实用肝脏病杂志, 2016, 19(1): 125-126.
[3]
Kaneda H,Hashimoto E,Yatsuji S, et al. Hyaluronic acid levels can predict severe fibrosis and platelet counts can predict cirrhosis in patients with nonalcoholic fatty liver disease[J]. J Gastroenterol Hepatol, 2006, 21(9): 1459-1465.
[4]
Leroy V,Monier F,Bottari S, et al.Circulating matrix metalloproteinases 1, 2, 9 and their inhibitors TIMP-1 and TIMP-2 as serum markers of liver fibrosis in patients with chronic hepatitis C: comparison with PⅢNP and hyaluronic acid[J]. Am J Gastroenterol, 2004, 99: 271-279.
[5]
Rosenberg WM,Voelker M,Thiel R, et al.Serum markers detect the presence of liver fibrosis: a cohort study[J]. Gastroenterology, 2004, 127(6): 1704-1713.
[6]
Sebastiani G,Vario A,Guido M, et al. Stepwise combination algorithms of non-invasive markers to diagnose significant fibrosis in chronic hepatitis C[J]. J Hepatol, 2006, 44(4): 686-693.
[7]
刘芳,魏琳,王珊珊, 等. 瞬时弹性成像技术联合血清学指标对慢性乙型肝炎肝纤维化的诊断价值研究[J]. 中国全科医学, 2016, 19(25): 3039-3044.
[8]
中华肝脏病学会肝纤维化学组. 肝纤维化诊断及疗效评估共识[J]. 中华肝脏病杂志, 2002, 10(5): 327-328.
[9]
Imbert-Bismut F,Ratziu V,Pieroni L, et al.Biochemical markers of liver fibrosis in patients with hepatitis C virus infection:a prospective study[J]. Lancet, 2001, 357(9262): 1069-1075.
[10]
Forns X,Ampurdanès S,Llovet JM, et al.Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model[J]. Hepatology, 2002, 36(4 Pt1): 986-992.
[11]
Wai CT,Greenson JK,Fontana RJ, et al.Asimplenon-invasive index canpredic both significant fibrosis and cirrhosis in patients with chronic hepatitis C[J]. Hepatology, 2003, 38(2): 518-526.
[12]
Zeng MD,Lu LG,Mao YM, et al.Prediction of significant fibrosis in HBeAg-positive patients with chronic hepatitis B by a noninvasive model[J]. Hepatology, 2005, 42(6): 1437-1445.
[13]
Sandrin L,Fourquet B,Hasquenoph JM, et al.Transient elastography:a new noninvasive method for assessment of hepatic fibrosis[J]. Ultrasound in Med Biol, 2003, 29(12): 1705-1713.
[14]
Castéra L,Vergniol J,Foucher J, et al.Prospective comparison of transient elastography, fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C[J]. Gastroenterology, 2005, 128(2): 343-350.
[15]
Ziol M,Handra-Luca A,Kettaneh A. Noninvassessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C[J]. Hepatology, 2005, 41(1): 48-54.
[16]
Matta B,Lee TH,Patel K, et al.Use of non-invasive testing to stage liver fibrosis in patients with HIV[J]. Curr HIV/AIDS Rep, 2016, 13(5): 279-288.
[17]
Foucher J,Chanteloup E,Vergniol J, et al.Diagnosis of cirrhosis by transientel as to graphy(FibroScan):aprospective study[J]. Gut, 2006, 55(3): 403-408.
[18]
王少春,张晓红,陈东风. 纤维板层型肝细胞癌临床诊断学特征分析并文献复习[J/CD]. 中华诊断学电子杂志, 2013, 1(1): 45-47.
[19]
胡根文, 全显跃,Queenie Chan, 等. 磁共振体素内不相干运动成像在大鼠肝纤维化模型中的应用[J]. 中国医学影像学杂志, 2016(9): 658-661.
[20]
Han KH,Yoon KT.New Diagnostic Method for Liver Fibrosis and Cirrhosis[J]. Intervirology, 2008(51): 11-16.
[21]
Aubé C,Racineux PX,Lebigot J, et al.Diagnosis and quantification of hepatic fibrosis with diffusion weighted MR imaging preliminary results[J]. J Radiol, 2004(85): 301-306.
[22]
Koinuma M,Ohashi I,Hanafusa K, et al.Apparent diffusion coefficient measurements with diffusion-weighted magnetic resonance imaging for evaluation of hepatic fibrosis[J]. J Magn Reson Imaging, 2005, 22(1): 80-85.
[23]
Girometti R,Furlan A,Bazzocchi M, et al.Diffusion-weighted MRI in evaluating liver fibrosis:a feasibility study in cirrhotic patients [J]. Radiol Med, 2007, 112(3): 394-408.
[24]
Shire NJ,Yin M,Chen J, et al. Test-retest repeatability of MR elastography for noninvasive liver fibrosis assessment in hepatitis C[J]. J Magn Reson Imaging, 2011, 34(4): 947-955.
[25]
Hines CD,Bley TA,Lindstrom MJ, et al.Repeatability of magnetic resonance elastography for quantification of hepatic stiffness[J]. J Magn Reson Imaging, 2010, 31(3): 725-731.
[26]
Yin M,Talwaikar JA,Glaser KJ, et al.Assessment of hepatic fibrosis with magnetic resonance elastography[J]. NMR Biomed, 2006, 19(2): 173-179.
[27]
黄燕平,郑永平. 基于磁共振的组织弹性测量[J]. 中国医疗设备, 2011, 26(12): 9-16.
[28]
Tan CH,Verkatesh SK.Magnetic resonance elastography and other magnetic resonance imaging techniques in chronic liver disease:current status and future directions[J]. Gut Liver, 2016, 10(5): 672-686.
[29]
徐铭益,张启迪,李正红, 等. 慢性乙型肝炎肝纤维化患者肝组织基因表达谱和功能分类[J]. 肝脏, 2013, 18(7): 435-438.
[30]
Venugopal SK,Jiang J,Kim TH, et al. Liver fibrosis causes downregulation of mi RNA-150 and mi RNA-194 in hepatic tellate cells, and their overexpression causes decreased stellate cell activation[J]. Am J Physiol Gastrointest Liver Physiol, 2010, 298(1): 101-106.
[1] 高建松, 陈晓晓, 冯婷, 包剑锋, 魏淑芳, 潘林. 基于超声瞬时弹性成像的多参数决策树模型评估慢性乙型肝炎患者肝纤维化等级[J]. 中华医学超声杂志(电子版), 2023, 20(09): 923-929.
[2] 骆云凯, 鄢曹鑫, 张宣宣, 李如梅, 王文倩, 洪行行, 夏斌, 邹伟璞, 张珊珊, 陈剑. 声触诊弹性成像检测脾硬度对诊断慢性乙肝肝纤维化程度的应用价值[J]. 中华医学超声杂志(电子版), 2022, 19(11): 1232-1237.
[3] 李沁园, 董常峰, 冯程, 李志艳, 刘李, 何秉昊, 姜伟, 田文硕, 杨帅. 基于弹性成像多模态法评估慢性乙型肝炎肝纤维化程度[J]. 中华医学超声杂志(电子版), 2022, 19(09): 976-982.
[4] 施娜, 邱文倩, 何丹青, 张超学, 毛萍, 杨艳婷. 瞬时弹性成像评价慢性乙型肝炎患者抗病毒治疗的效果[J]. 中华医学超声杂志(电子版), 2022, 19(05): 428-433.
[5] 王璐, 樊杨. 子宫内膜癌相关生物标志物研究现状[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 511-516.
[6] 刘仕茜, 屈艺, 应俊杰, 母得志. 液体活检在新生儿脑损伤诊断及预后判断中的应用和展望[J]. 中华妇幼临床医学杂志(电子版), 2022, 18(02): 125-131.
[7] 曹杨, 刘瀚旻. 生物标志物在新生儿脓毒症中的应用研究进展[J]. 中华妇幼临床医学杂志(电子版), 2021, 17(06): 643-649.
[8] 王淑惠, 薛梅. 新生儿高胆红素血症所致脑损伤患儿的早期监测研究现状[J]. 中华妇幼临床医学杂志(电子版), 2021, 17(06): 634-642.
[9] 杨蕾, 肖东琼, 钟亦思. 口腔菌群与儿童常见非口腔性疾病的关系[J]. 中华妇幼临床医学杂志(电子版), 2021, 17(05): 510-515.
[10] 任明霞, 李坑, 金发光, 刘一, 李相生, 潘蕾. 51例非感染性肺空洞疾病的临床分析[J]. 中华肺部疾病杂志(电子版), 2021, 14(05): 584-589.
[11] 吕靖芳, 黄海洋, 刘恩瑞, 庄孟, 王锡山. PD-1抗体/PD-L1抗体在结直肠癌治疗中的应用现状及展望[J]. 中华结直肠疾病电子杂志, 2023, 12(01): 70-74.
[12] 丁茜, 李振, 王思宁, 赵连晖, 王广川, 张春清. 人肝窦内皮细胞中α1肾上腺素能受体亚型表达的初步实验研究[J]. 中华消化病与影像杂志(电子版), 2022, 12(02): 98-101.
[13] 马四海, 杨剑, 马显武, 张敏, 吕明礼, 李启菊, 杨轶声, 刘海生. Shamblin Ⅱ型颈动脉体瘤的诊疗及文献综述[J]. 中华临床医师杂志(电子版), 2023, 17(04): 467-470.
[14] 刘志强, 窦项洁, 刘白露, 董晓萌, 鲍俊宇. 银杏达莫注射液对大鼠肝缺血再灌注损伤的保护作用机制研究[J]. 中华诊断学电子杂志, 2022, 10(04): 259-265.
[15] 苏畅, 梁秋华, 孙琳. 微小RNA与糖尿病周围神经病变研究进展[J]. 中华诊断学电子杂志, 2021, 09(04): 285-288.
阅读次数
全文


摘要